protein kinase C, delta |
PIPERACILLIN |
Phorbol Ester |
-12% |
NoneNone |
NoneNone |
View
|
protein kinase C, mu |
PIPERACILLIN |
Phorbol Ester |
-12% |
NoneNone |
NoneNone |
View
|
protein kinase C, theta |
PIPERACILLIN |
Phorbol Ester |
-12% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
PIPERACILLIN |
Phorbol Ester |
-12% |
NoneNone |
NoneNone |
View
|
protein kinase C, epsilon |
PIPERACILLIN |
Phorbol Ester |
-12% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
DIMENHYDRINATE |
Phorbol Ester |
-12% |
NoneNone |
NoneNone |
View
|
protein kinase C, beta 1 |
DIMENHYDRINATE |
Phorbol Ester |
-12% |
NoneNone |
NoneNone |
View
|
protein kinase C, delta |
DIMENHYDRINATE |
Phorbol Ester |
-12% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
PHENOL |
Cyclooxygenase COX-1 |
-12% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
PHENOL |
Cyclooxygenase COX-1 |
-12% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
BETA-NAPHTHOFLAVONE |
Chemokine CCR4 |
-12% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
4-(2-THIENYL)BUTYRIC ACID |
Chemokine CCR4 |
-12% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
TRICHLOROACETIC ACID |
Chemokine CCR5 |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
PENICILLIN G |
Adrenergic alpha2A |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
PHENACETIN |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
PHENACETIN |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
PHENACETIN |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
PHENACETIN |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
SOTALOL |
Dopamine D3 |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
PHENACETIN |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
PHENACETIN |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 3, endothelial cell |
DOXOFYLLINE |
Nitric Oxide Synthase, Constitutive (cNOS) |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
PHENTOLAMINE |
Glutamate, NMDA, Agonism |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
PHENTOLAMINE |
Glutamate, NMDA, Agonism |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
PHENTOLAMINE |
Glutamate, NMDA, Agonism |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
PHENTOLAMINE |
Glutamate, NMDA, Agonism |
-13% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
PHENTOLAMINE |
Glutamate, NMDA, Agonism |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
PHENTOLAMINE |
Glutamate, NMDA, Agonism |
-13% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 3 (endothelial cell) |
DOXOFYLLINE |
Nitric Oxide Synthase, Constitutive (cNOS) |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
SALICYLIC ACID |
Imidazoline I2, Central |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
SALICYLIC ACID |
Imidazoline I2, Central |
-13% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
ARTEMETHER |
CYP450-1A2 Inhibition |
-13% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
PHENACETIN |
Serotonin 5-HT2B |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
PROPOFOL |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
PROPOFOL |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
PROPOFOL |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
PROPOFOL |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
PROPOFOL |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
SB-203580 |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
SB-203580 |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
SB-203580 |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
SB-203580 |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
SB-203580 |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
PROPOFOL |
Adenosine A2A |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
PHENYTOIN |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
PHENYTOIN |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
PHENYTOIN |
GABAA, Agonist Site |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
PHENYLHYDRAZINE |
Adrenergic alpha2B |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
PRAVASTATIN |
Adrenergic beta1 |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
PRAVASTATIN |
Adrenergic beta1 |
-13% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
SULFAPHENAZOLE |
Leukotriene D4 |
-13% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
SULFAPHENAZOLE |
Leukotriene D4 |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
DEFERIPRONE |
Adrenergic beta1 |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
DEFERIPRONE |
Adrenergic beta1 |
-13% |
NoneNone |
NoneNone |
View
|
opioid receptor, sigma 1 |
AMPIROXICAM |
Sigma1 |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
AMPRENAVIR |
Adrenergic alpha1A |
-13% |
NoneNone |
NoneNone |
View
|
caspase 1 |
EBASTINE |
Protease, Caspase 1 |
-13% |
NoneNone |
NoneNone |
View
|
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) |
EBASTINE |
Protease, Caspase 1 |
-13% |
NoneNone |
NoneNone |
View
|
caspase 3, apoptosis related cysteine protease |
EBASTINE |
Protease, Caspase 1 |
-13% |
NoneNone |
NoneNone |
View
|
caspase 2 |
EBASTINE |
Protease, Caspase 1 |
-13% |
NoneNone |
NoneNone |
View
|
caspase 7 |
EBASTINE |
Protease, Caspase 1 |
-13% |
NoneNone |
NoneNone |
View
|
caspase 6 |
EBASTINE |
Protease, Caspase 1 |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
ALENDRONIC ACID |
Muscarinic M2 |
-13% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
PARTHENOLIDE |
Serotonin 5-HT4 |
-13% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
PARTHENOLIDE |
Serotonin 5-HT4 |
-13% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
PRIMAQUINE |
Estrogen ERalpha |
-13% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
PRIMAQUINE |
Estrogen ERalpha |
-13% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
POLYVINYL ALCOHOL |
Potassium Channel [KATP] |
-13% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
POLYVINYL ALCOHOL |
Potassium Channel [KATP] |
-13% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
POLYVINYL ALCOHOL |
Potassium Channel [KATP] |
-13% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
SALICYLAMIDE |
Adrenergic, Norepinephrine Transporter |
-13% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
TOSUFLOXACIN |
Serotonin 5-HT3 |
-13% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
TOSUFLOXACIN |
Serotonin 5-HT3 |
-13% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 4 |
SELEGILINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-13% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
SELEGILINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-13% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
SELEGILINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
SELEGILINE |
Calcium Channel Type L, Benzothiazepine |
-13% |
NoneNone |
NoneNone |
View
|
insulin receptor |
LETROZOLE |
Insulin |
-13% |
NoneNone |
NoneNone |
View
|
insulin receptor |
LETROZOLE |
Insulin |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
PROPRANOLOL |
Glutamate, AMPA |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
PROPRANOLOL |
Glutamate, AMPA |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
PROPRANOLOL |
Glutamate, AMPA |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
PROPRANOLOL |
Glutamate, AMPA |
-13% |
NoneNone |
NoneNone |
View
|
platelet-activating factor receptor |
TIAPRIDE |
Platelet Activating Factor (PAF) |
-13% |
NoneNone |
NoneNone |
View
|
opioid receptor, delta 1 |
LEVODOPA |
Opiate delta |
-13% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
FUROSEMIDE |
CYP450-2C19 Inhibition |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
RISEDRONIC ACID |
Adrenergic alpha1A |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
RISEDRONIC ACID |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
IRINOTECAN |
Serotonin 5-HT2C |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
SULFADIMETHOXINE |
Adrenergic alpha1A |
-13% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
RISEDRONIC ACID |
Interleukin IL-1 alpha |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
LIDOCAINE |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
LIDOCAINE |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
LIDOCAINE |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
LIDOCAINE |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
LIDOCAINE |
Glutamate, Kainate |
-13% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
CAPSAICIN |
Leukotriene D4 |
-13% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
CAPSAICIN |
Leukotriene D4 |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
5-FLUORO-2'-DEOXYURIDINE |
Neuropeptide Y1 |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DIAZOXIDE |
Calcium Channel Type L, Phenylalkylamine |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
FLUPHENAZINE |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
FLUPHENAZINE |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
FLUPHENAZINE |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
FLUPHENAZINE |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
FLUPHENAZINE |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
FLUPHENAZINE |
Nicotinic Acetylcholine, Central |
-13% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
IPRIFLAVONE |
Leukotriene D4 |
-13% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
IPRIFLAVONE |
Leukotriene D4 |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
THIAMPHENICOL |
Glutamate, NMDA, Phencyclidine |
-13% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
THIAMPHENICOL |
Glutamate, NMDA, Phencyclidine |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
THIAMPHENICOL |
Glutamate, NMDA, Phencyclidine |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
THIAMPHENICOL |
Muscarinic M1 |
-13% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
THIAMPHENICOL |
Vasoactive Intestinal Peptide VIP1 |
-13% |
NoneNone |
NoneNone |
View
|
nuclear receptor subfamily 3, group C, member 1 |
DIAZOXIDE |
Glucocorticoid |
-13% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
DIAZOXIDE |
Muscarinic M5 |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
THIAMPHENICOL |
Glutamate, NMDA, Phencyclidine |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
THIAMPHENICOL |
Glutamate, NMDA, Phencyclidine |
-13% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
THIAMPHENICOL |
Glutamate, NMDA, Phencyclidine |
-13% |
NoneNone |
NoneNone |
View
|
nuclear receptor subfamily 3, group C, member 1 |
DYPHYLLINE |
Glucocorticoid |
-13% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
DYPHYLLINE |
Adrenergic beta2 |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Dihydropyridine |
-13% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIDANOSINE |
Calcium Channel Type L, Phenylalkylamine |
-12% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
AZARIBINE |
CYP450-2C19 Inhibition |
-12% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
4-(2-THIENYL)BUTYRIC ACID |
Adrenergic beta2 |
-12% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1b |
PHENOL |
Adrenergic alpha1B |
-12% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
AZARIBINE |
Adrenergic alpha2A |
-12% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
DIDANOSINE |
Adrenergic alpha2B |
-12% |
NoneNone |
NoneNone |
View
|